USPTO serial 79349978
MATRIXOME
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 11, 2023
- Examiner
- SCHLEGELMILCH, JONATHON A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MATRIXOME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Proteins for use in the manufacture of pharmaceuticals and biological preparations other than for medical or veterinary use; proteins in raw material form for scientific and medical research use to enhance cell proliferation and viability, other than for medical or veterinary use; proteins in raw material form for scientific and medical research use as substrates in cell cultures, other than for medical or veterinary use; biological reagents for scientific and medical research use in cell cultures other than for medical or veterinary use; chemical preparations for scientific and medical research use in cell cultures other than for medical or veterinary use; chemical reagents for use in cell cultures other than for medical or veterinary use; proteins in raw material form for scientific and medical research, other than for medical or veterinary use; chemical preparations for scientific and medical research use other than for medical or veterinary use; chemical reagents other than for medical or veterinary use | ACTIVE | — |
| 005 | Cell culture substrates, namely, protein specifically adapted for use with nucleic acid sequences for use in cell cultures for medical, clinical, and veterinary diagnostic use; reagents for use in cell cultures for medical, clinical medical, and veterinary diagnostic use; recombinant protein being biochemical preparations specially adapted for use with nucleic acid sequences for medical purposes; chemical reagents for medical and veterinary use; chemical preparations for medical purposes, namely, reagents for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 11, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 5, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 16, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 16, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 11, 2023 | GPAR | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | — |
| Apr 11, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 25, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 24, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 4, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 4, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 4, 2023 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 20, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 9, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 30, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 26, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 22, 2022 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Sep 16, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |